TASER ACCELERATION Continues and 4 Fresh Stock Analyses to See Now

Boston Scientific Corporation (NYSE:BSX) reported lower Q2 sales than expected but higher gross margins than expected. RBC Capital predicts that the gross margins of the company will improve. The firm believes that the company’s businesses, excluding CRM/stents, will keep improving in the mid single digit percentage level, and it thinks the stent business will start to stabilize. It keeps its Outperform rating on the stock.

Don’t Miss: Merck Earnings: Expands Margins AGAIN, TOPS Analyst Estimates.

Cliffs Natural Resources Inc. (NYSE:CLF) target was lowered by RBC Capital after the company reported weaker than expected Q2 results, but the firm thinks that most of the bad news is now reflected in the stock. The firm keeps an Outperform rating on the stock.

Kimberly-Clark Corporation (NYSE:KMB) target was raised by RBC Capital after the company reported stronger than expected Q2 results and increasing its FY12 guidance. The firm believes that investor sentiment towards the company is positioned to improve this year, and it keeps an Outperform rating on the stock.

Rush Enterprises, Inc. (NASDAQ:RUSHA) reported higher than expected revenue but lower than expected margins causing RBC Capital to expect the company’s orders to accelerate. The firm keeps its Outperform rating lowered its target to $20 from $28 on the stock.

TASER International Inc. (NASDAQ:TASR)  has been upgraded by Craig-Hallum due to its exceptional cash flow and margins, accelerating growth, significant upgrade cycle, and a new video product which could be a new “cash machine.” Shares have a Buy rating.

Don’t Miss: Apple Catches a Break — For Now.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.